المؤلفون: Koivula, R.W., Heggie, A., Barnett, A., Cederberg, H., Hansen, T.H., Koopman, A.D., Ridderstråle, M., Rutters, F., Vestergaard, H., Gupta, R., Herrgård, S., Heymans, M.W., Perry, M.H., Rauh, S., Siloaho, M., Teare, H.J., Thorand, B., Bell, J., Brunak, S., Frost, G., Jablonka, B., Mari, A., McDonald, T.J., Dekker, J.M., Hansen, T., Hattersley, A., Laakso, M., Pedersen, O., Koivisto, V., Ruetten, H., Walker, M., Pearson, E., Franks, P.W., DIRECT Consortium ()

المساهمون: Epidemiology and Data Science, EMGO - Lifestyle, overweight and diabetes, APH - Methodology, CCA - Immuno-pathogenesis, Methodology and Applied Biostatistics, EMGO+ - Lifestyle, Overweight and Diabetes

المصدر: Diabetologia 57, 1132-1142 (2014)
Koivula, R W, Heggie, A, Barnett, A, Cederberg, H, Hansen, T H, Koopman, A, Ridderstrale, M, Rutters, F, Vestergaard, H, Gupta, R, Herrgard, S, Heymans, M W, Perry, M H, Rauh, S, Siloaho, M, Teare, H J A, Thorand, B, Bell, J, Brunak, S, Frost, G, Jablonka, B, Mari, A, McDonald, T J, Dekker, J M, Hansen, T, Hattersley, A, Laakso, M, Pedersen, O, Koivisto, V, Ruetten, H, Walker, M, Pearson, E & Franks, P W 2014, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 57, no. 6, pp. 1132-1142 . https://doi.org/10.1007/s00125-014-3216-xTest
Diabetologia
Diabetologia (Berl.) 57 (2014): 1132–1142. doi:10.1007/s00125-014-3216-x
info:cnr-pdr/source/autori:Koivula R.W.; Heggie A.; Barnett A.; Cederberg H.; Hansen T.H.; Koopman A.D.; Ridderstrale M.; Rutters F.; Vestergaard H.; Gupta R.; Herrgard S.; Heymans M.W.; Perry M.H.; Rauh S.; Siloaho M.; Teare H.J.A.; Thorand B.; Bell J.; Brunak S.; Frost G.; Jablonka B.; Mari A.; McDonald T.J.; Dekker J.M.; Hansen T.; Hattersley A.; Laakso M.; Pedersen O.; Koivisto V.; Ruetten H.; Walker M.; Pearson E.; Franks P.W./titolo:Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: Rationale and design of the epidemiological studies within the IMI DIRECT Consortium/doi:10.1007%2Fs00125-014-3216-x/rivista:Diabetologia (Berl.)/anno:2014/pagina_da:1132/pagina_a:1142/intervallo_pagine:1132–1142/volume:57
Diabetologia; 57(6), pp 1132-1142 (2014)
Koivula, R W, Heggie, A, Barnett, A, Cederberg, H, Hansen, T H, Koopman, A D, Ridderstrale, M, Rutters, F, Vestergaard, H, Gupta, R, Herrgard, S, Heymans, M W, Perry, M H, Rauh, S, Siloaho, M, Teare, H J A, Thorand, B, Bell, J, Brunak, S, Frost, G, Jablonka, B, Mari, A, McDonald, T J, Dekker, J M, Hansen, T, Hattersley, A, Laakso, M, Pedersen, O, Koivisto, V, Ruetten, H, Walker, M, Pearson, E & Franks, P W 2014, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 57, no. 6, pp. 1132-1142 . https://doi.org/10.1007/s00125-014-3216-xTest
Koivula, R W, Heggie, A, Barnett, A, Cederberg, H, Hansen, T H, Koopman, A D, Ridderstrale, M, Rutters, F, Vestergaard, H, Gupta, R, Herrgard, S, Heymans, M W, Perry, M H, Rauh, S, Siloaho, M, Teare, H J A, Thorand, B, Bell, J, Brunak, S, Frost, G, Jablonka, B, Mari, A, McDonald, T J, Dekker, J M, Hansen, T, Hattersley, A, Laakso, M, Pedersen, O, Koivisto, V, Ruetten, H, Walker, M, Pearson, E, Franks, P W & Consortium, D 2014, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes : Rationale and design of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 57, no. 6, pp. 1132-1142 . https://doi.org/10.1007/s00125-014-3216-xTest
Diabetologia, 57(6), 1132-1142. Springer Verlag

مصطلحات موضوعية: Blood Glucose, Male, Gerontology, Epigenetic, Gene-environment Interaction, Genome, Glycaemic Control, Lifestyle, Microbiome, Prediabetes, Proteome, Transcriptome, Type 2 Diabetes, Epidemiology, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Disease, 0302 clinical medicine, Pregnancy, HISTORY, Glycaemic control, Prospective Studies, POPULATION, 0303 health sciences, education.field_of_study, INSULIN SENSITIVITY, Diabetes, Middle Aged, GOLDBERG CUTOFF, 3. Good health, CARDIOVASCULAR-DISEASE, HASH(0x5038388), Cohort, Female, Diabetes Mellitus, Type 2/blood, Life Sciences & Biomedicine, Adult, medicine.medical_specialty, ENDOCRINOLOGY & METABOLISM, Population, MEDLINE, Hypoglycemic Agents/therapeutic use, 030209 endocrinology & metabolism, Endocrinology and Diabetes, Article, 03 medical and health sciences, Blood Glucose/drug effects, SDG 17 - Partnerships for the Goals, SDG 3 - Good Health and Well-being, Diabetes mellitus, Internal Medicine, medicine, Humans, Hypoglycemic Agents, COHORT, Gene–environment interaction, education, Intensive care medicine, Aged, 030304 developmental biology, Science & Technology, business.industry, CONSUMPTION, medicine.disease, Gene-environment interaction, Epidemiologic Studies, ENDOCRINOLOGY, Diabetes Mellitus, Type 2, RISK-FACTORS, GLUCOSE-TOLERANCE, business, Biomarkers/blood, RESISTANCE, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f574ea53f4ebec05036ab9eafdc85a21Test
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=31036Test

المؤلفون: Chaturvedi, N, Stevenson, J, Fuller, Jh, Rottiers, R, Ferriss, B, Karamanos, B, Kofinis, A, Petrou, C, Ionescutirgovisite, C, Iosif, C, Tamas, G, Bibok, G, Kerenyi, Z, Kisgombos, P, Toth, J, Grealy, G, Priem, H, Koivisto, V, Tuominen, J, Kostamo, E, Idziorwalus, B, Solnica, B, Galickalatalie, D, Michel, G, Keipes, M, Giuliani, A, Herode, A, Santeusanio, F, Bueti, A, Bistoni, S, Cagini, Navalesi, R, Penno, G, Nannipieri, Monica, Rizzo, L, Miccoli, Roberto, Ghirlanda, G, Cotroneo, P, Manto, A, Minella, A, Saponara, C, Ward, J, Plater, M, Ibrahim, S, Ibbotson, S, Mody, C, Papazoglou, N, Manes, C, Soulis, K, Voukias, M, Muggeo, M, Cacciatori, V, Gemma, Ml, Dellera, A, Castellarin, A, Irsigler, K, Abrahamian, H, Gurdet, C, Willinger, C, Nelstrop, A, Feben, C, Walford, S, Mclelland, V, Hughes, S, Metelko, Z, Roglic, G, Pepeonik, Zr, Stephenson, J, Viberti, Gc, Sjolie, Ak, Holloway, J, Milne, M, Webb, D, Bulpitt, C, Fletcher, A, Shipley, M, John, G, Newman, Dj

المصدر: The Lancet. 349:1787-1792

مصطلحات موضوعية: medicine.medical_specialty, Proteinuria, endocrine system diseases, business.industry, Urology, Lisinopril, Renal function, Captopril, General Medicine, urologic and male genital diseases, Placebo, medicine.disease, Endocrinology, Internal medicine, ACE inhibitor, medicine, Albuminuria, Microalbuminuria, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9a471d480a2e4e1232c281d56a2969Test
https://doi.org/10.1016/s0140-6736Test(96)10244-0

المؤلفون: Peeters, Stijn A., Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H., Schalkwijk, Casper G., Stehouwer, Coen D, Karamanos, B., Kofinis, A., Petrou, K., Giorgino, F., Picca, G., Angarano, A., Null, de P. e. r. g. o. l. a. G., Laviola, L., Giorgino, R., Ionescu Tirgoviste, C., Coszma, A., Guja, C., Songini, M., Casu, A., Pedron, M., Pintus, S., Fossarello, M., Ferriss, J. B., Grealy, G., O'Keefe, D., Toeller, M., Arden, C., Rottiers, R., Tuyttens, C., Priem, H., Ebeling, P., Kylliainen, M., Koivisto, V. A., Idzior Walus, B., Sieradzki, J., Cyganek, K., Solnica, B., Lemkes, H. H. P. J., Lemkes Stuffken, J. C., Nunes Correa, J., Rogado, M. C., Gardete Correia, L., Cardoso, M. C., Silva, A., Boavida, J., Machado Sa Marques, M., Michel, G., Wirion, R., Cardillo, S., Pozza, G., Mangili, R., Asnaghi, V., Standl, E., Schaffler, B., Brand, H., Harms, A., Ben Soussan, M., Verier Mine, O., Fallas, P., Fallas, M. C., Fuller, J. H., Holloway, J., Asbury, L., Betteridge, D. J., Cathelineau, G., Bouallouche, A., Villatte Cathelineau, B., Santeusanio, F., Rosi, G., D'Alessandro, V., Cagini, C., Bottini, P., Reboldi, G. P., Navalesi, R., Penno, Giuseppe, Bandinelli, S., Miccoli, Roberto, Nannipieri, Monica, Ghirlanda, G., Saponara, C., Cotroneo, P., Manto, A., Minnella, A., Ward, J. D., Tesfaye, S., Eaton, S., Mody, C., Borra, M., Cavallo Perin, P., Giunti, S., Grassi, G., Pagano, G. F., Porta, M., Sivieri, R., Vitelli, F., Veglio, M., Papazoglou, N., Manes, G., Muggeo, M., Iagulli, M., Cacciatori, V., Cattedra di Malattie del Metabolismo, V., Irsigler, K., Abrahamian, H., Walford, S., Sinclair, J., Hughes, S., Mclelland, V., Ward, J., Roglic, G., Metelko, Z., Pepeonik, Z. R.

المساهمون: Clinicum, Department of Medicine, Interne Geneeskunde, MUMC+: MA Interne Geneeskunde (3), RS: CARIM - R3 - Vascular biology

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, 14:31. BioMed Central Ltd

مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Matrix metalloproteinase, Gastroenterology, Cohort Studies, Endocrinology, Prospective Studies, Endothelial dysfunction, Original Investigation, Settore MED/30 - MALATTIE APPARATO VISIVO, Middle Aged, Cardiovascular disease, 3. Good health, Europe, Diabetes and Metabolism, Albuminuria, Retinopathy, Tissue inhibitor of metalloproteinase, Type 1 diabetes, Adult, Biomarkers, Cross-Sectional Studies, Diabetes Complications, Diabetes Mellitus, Type 1, Female, Humans, Matrix Metalloproteinase 10, Matrix Metalloproteinase 2, Matrix Metalloproteinase 3, Tissue Inhibitor of Metalloproteinase-1, Vascular Diseases, Cardiology and Cardiovascular Medicine, medicine.symptom, Type 1, medicine.medical_specialty, education, Inflammation, Diabetes mellitus, Internal medicine, medicine, Diabetes Mellitus, business.industry, Settore MED/09 - MEDICINA INTERNA, medicine.disease, 3121 General medicine, internal medicine and other clinical medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78226d7d86ee0e00241b8f5e4f5f1456Test